MCHP Form 4: Director Matthew Chapman Sells 10,000 Shares

Q: What transaction did Matthew W. Chapman report on Form 4 for MCHP?

He reported a sale of 10,000 common shares on 08/25/2025 at a price of $68.255 per share.

Q: How many MCHP shares does the reporting person own after the reported transaction?

The Form 4 shows the reporting person beneficially owned 30,665 shares following the sale.

Q: Were any derivative securities reported in this Form 4 for MCHP?

No. The filing shows no derivative securities were acquired, disposed of, or beneficially owned.

Q: Who signed the Form 4 and when was it signed?

The form was signed by Deborah L. Wussler, as Attorney-in-Fact on 08/27/2025.

Q: Does this Form 4 indicate the reporting person is an officer or director of MCHP?

Yes. The filing identifies the reporting person as a Director of Microchip Technology Inc.

Matthew W. Chapman, a director of Microchip Technology Inc. (MCHP), reported a sale of 10,000 shares of the issuer's common stock on 08/25/2025 at a reported price of $68.255 per share.

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Matthew W. Chapman, a director of Microchip Technology Inc. (MCHP), reported a sale of 10,000 shares of the issuer's common stock on 08/25/2025 at a reported price of $68.255 per share. After the sale, Mr. Chapman beneficially owned 30,665 shares, held directly. The Form 4 indicates no derivative transactions and was signed on behalf of the reporting person by an attorney-in-fact on 08/27/2025.

Positive

None.

Negative

Director sale of 10,000 shares on 08/25/2025 at $68.255 per share, reducing the reporting person's holdings

Insights

TL;DR: Director sale reported; small direct shareholding remains and no derivatives were involved.

The Form 4 documents a straightforward open-market sale by a company director: 10,000 common shares disposed at $68.255 each, leaving 30,665 shares beneficially owned directly. The filing shows no derivative positions or additional compensatory transactions. For investors, this is a routine Section 16 disclosure that documents insider liquidity but does not, by itself, indicate broader corporate changes.

Insider Trade Summary

Net Seller: 10,000 shares

Net Sell 1 txn

Insider CHAPMAN MATTHEW W

Role Director

Sold 10,000 shs ($683K)

Type	Security	Shares	Price	Value
Sale	Common Stock	10,000	$68.255	$683K

Holdings After Transaction: Common Stock — 30,665 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did Matthew W. Chapman report on Form 4 for MCHP?

He reported a sale of 10,000 common shares on 08/25/2025 at a price of $68.255 per share.

How many MCHP shares does the reporting person own after the reported transaction?

The Form 4 shows the reporting person beneficially owned 30,665 shares following the sale.

Were any derivative securities reported in this Form 4 for MCHP?

No. The filing shows no derivative securities were acquired, disposed of, or beneficially owned.

Who signed the Form 4 and when was it signed?

The form was signed by Deborah L. Wussler, as Attorney-in-Fact on 08/27/2025.

Does this Form 4 indicate the reporting person is an officer or director of MCHP?

Yes. The filing identifies the reporting person as a Director of Microchip Technology Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/27/2025 - 04:41 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHAPMAN MATTHEW W

(Last)

(First)

(Middle)

C/O MICROCHIP TECHNOLOGY INCORPORATED

2355 WEST CHANDLER BOULEVARD

(Street)

CHANDLER

85224-6199

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROCHIP TECHNOLOGY INC [ MCHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/25/2025		S		10,000	D	$68.255	30,665	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

Remarks:

	Deborah L. Wussler, as Attorney-in-Fact	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

MCHP Form 4: Director Matthew Chapman Sells 10,000 Shares